Change of erectile function and responsiveness to phosphodiesterase type 5 inhibitors at different stages of streptozotocin-induced diabetes in rats

Journal of Sexual Medicine

Volumn 8, Issue 5, 2011, Pages 1352-1361

  Cho, Sung Yong ^a   Park, Kwanjin ^a   Paick, Jae Seung ^a   Kim, Soo Woong ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Diabetes; Erectile Dysfunction; RhoA Rho kinase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MYOSIN; PHOSPHATASE; RHO KINASE; UDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; IMMUNOHISTOCHEMISTRY; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STIMULUS RESPONSE; STREPTOZOCIN DIABETES; UPREGULATION; WESTERN BLOTTING;

EID: 79955141050     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02099.x     Document Type: Article

References (34)

1. Sáenz de Tejada I, Angulo J, Cellek S, González-Cadavid N, Heaton J, Pickard R, Simonsen U. Pathophysiology of erectile dysfunction. J Sex Med 2005;2:26-39.
2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
3. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005;47:80-5.
4. Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2002;14:466-71.
5. Costabile RA. Optimizing treatment for diabetes mellitus induced erectile dysfunction. J Urol 2003;170:S35-8.
6. Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrinol Metab Clin North Am 1996;25:379-400.
7. Fedele D, Bortolotti A, Coscelli C, Santeusanio F, Chatenoud L, Colli E, Lavezzari M, Landoni M, Parazzini F. Erectile dysfunction among type 1 and type 2 diabetics in Italy. Int J Epidemiol 2000;29:524-31.
8. Romeo JR, Seftel AD, Madhum Z. Sexual function in men with diabetes type 2: Association with glycemic control. J Urol 2000;163:788-91.
9. Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002;25:1458-63.
10. Lu CC, Jiann BP, Sun CC, Lam HC, Chu CH, Lee JK. Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med 2009;6:1719-28.
11. Ari G, Vardi Y, Finberg JP. Nitric oxide and penile erection in streptozotocin-diabetic rats. Clin Sci (Lond) 1999;96:365-71.
12. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003;52:2353-62.
13. Melman A, Zotova E, Kim M, Arezzo J, Davies K, DiSanto M, Tar M. Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats. BJU Int 2009;104:1292-300.
14. Bivalacqua TJ, Champion HC, Usta MF, Cellek S, Chitaley K, Webb RC, Lewis RL, Mills TM, Hellstrom WJG, Kadowitz PJ. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA 2004;101:9121-6.
15. Wingard C, Fulton D, Husain S. Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat. J Sex Med 2007;4:348-62.
16. Morelli A, Chavalmane AK, Filippi S, Fibbi B, Silvestrini E, Sarchielli E, Zhang XH, Vignozzi L, Vannelli GB, Forti G, Maggi M. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. J Sex Med 2009;6:91-106.
17. Alici B, Gümüstas MK, Ozkara H, Akkus E, Demirel G, Yencilek F, Hattat H. Apoptosis in the erectile tissues of diabetic and healthy rats. BJU Int 2000;85:326-9.
18. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Tsujimura A, Matsumiya K, Okuyama A, Dahiya R. Diabetes induced erectile dysfunction and apoptosis in penile crura are recovered by insulin treatment in rats. J Urol 2003;170:291-7.
19. Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Pioglitazone prevents corporal venoocclusive dysfunction in a rat model of type 2 diabetes mellitus. BJU Int 2006;98:116-24.
20. Park K, Ryu KS, Li WJ, Kim SW, Paick JS. Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction. Eur Urol 2008;53:1282-8.
21. Li WJ, Park K, Paick JS, Kim SW. Chronic treatment with an oral Rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats. J Sex Med 2010; Mar 2 [Epub ahead of print]. doi: 10.1111/j.1743-6109.2010.01724.x.
22. Yu JY, Kang KK, Yoo M, Kwon JW. Penile erectile responses to electric stimulation are enhanced by a new phosphodiesterase type-5 inhibitor. Int J Urol 2005;12:299-304.
23. Allard J, Edmunds NJ. Reflex penile erection in anesthetized mice: An exploratory study. Neuroscience 2008;155:283-90.
24. Park K, Kim SW, Ryu KS, Paick J-S. Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model. J Sex Med 2006;3:996-1003.
25. Bivalacqua TJ, Usta MF, Champion HC, Leungwattanakij S, Dabisch PA, McNamara DB, Kadowitz PJ, Hellstrom WJ. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int J Impot Res 2004;16:21-9.
26. Angulo J, Cuevas P, Gabancho S, Gonzalez-Corrochano R, Videla S, Saenz de Tejada I. Enhancement of both EDHF and NO/cGMP pathways is necessary to reverse erectile dysfunction in diabetic rats. J Sex Med 2005;2:341-6.
27. Ueno N, Iwamoto Y, Segawa N, Kinoshita M, Ueda H, Katsuoka Y. The effect of sildenafil on electrostimulation-induced erection in the rat model. Int J Impot Res 2002;14:251-5.
28. Benet AE, Rehman J, Holcomb RG, Melman A. The correlation between the new RigiScan plus software and the final diagnosis in the evaluation of erectile dysfunction. J Urol 1996;156:1947-50.
29. Wespes E, Goes PM, Schiffmann S, Depierreux M, Vanderhaeghen JJ, Schulman CC. Computerized analysis of smooth muscle fibers in potent and impotent patients. J Urol 1991;146:1015-7.
30. El-Sakka AI, Lin CS, Chui RM, Dahiya R, Lue TF. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int J Impot Res 1999;11:123-32.
31. Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, Forti G, Maggi M. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006;3:253-64.
32. Musicki B, Burnett AL. eNOS function and dysfunction in the penis. Exp Biol Med (Maywood) 2006;231:154-65.
33. Malavige LS, Levy JC. Erectile dysfunction in diabetes Mellitus. J Sex Med 2009;6:1232-47.
34. Vignozzi L, Morelli A, Filippi S, Ambrosini S, Mancina R, Luconi M, Mungai S, Vannelli GB, Zhang XH, Forti G, Maggi M. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. J Sex Med 2007;4:620-30.